| Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304) |
|---|
| 09/29/2004 | EP1461313A1 Human adam-10 inhibitors |
| 09/29/2004 | EP1461083A1 Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and protein kinase (serine/threonine kinase) inhibitors |
| 09/29/2004 | EP1461038A1 Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders |
| 09/29/2004 | EP1461026A2 Method for treating ocular hypertension |
| 09/29/2004 | EP1351941B1 Bisaryl derivatives having fsh receptor modulatory activity |
| 09/29/2004 | EP1200400B1 Substituted pyrrolidin-2,3,4-trion derivatives useful as nmda-receptor antagonists |
| 09/29/2004 | EP1192189B1 Catalysts containing n-pyrrolyl substituted nitrogen donors |
| 09/29/2004 | EP1051397A4 Method for preparing an n- (aliphatic or aromatic)carbonyl]-2-aminoacetamide compound and a cyclyzed compound |
| 09/29/2004 | EP1028961B1 Pleuromutilin derivatives as antimicrobials |
| 09/29/2004 | EP1019040B1 Aryl ureas for the treatment of inflammatory or immunomodulatory diseases |
| 09/29/2004 | EP1012140B1 New amidino derivatives and their use as thrombin inhibitors |
| 09/29/2004 | CN1533382A 哌嗪衍生物 Piperazine derivatives |
| 09/29/2004 | CN1533376A Method for producing pyrrolidones |
| 09/29/2004 | CN1168714C Arylpiperazine derivatives useful as uroselective alpha-adrenoceptor blockers |
| 09/29/2004 | CN1168713C Synthetic reoutes for the preparation of rhionvirus protease inhibitor and key intermediates |
| 09/28/2004 | US6797848 Anthracene derivative and organic electroluminescence device using the derivative |
| 09/28/2004 | US6797829 Synthesis of a novel paramagnetic amino derivative (epm-5) for labelling chemical and biological macromolecules |
| 09/28/2004 | US6797820 Succinate compounds, compositions and methods of use and preparation |
| 09/28/2004 | US6797731 Resorcinol derivatives |
| 09/28/2004 | US6797723 Heterocycle substituted diphenyl leukotriene antagonists |
| 09/28/2004 | CA2224125C Pharmaceutical composition comprising a proteinase inhibitor and a monoglyceride |
| 09/23/2004 | WO2004081643A1 Lenslet array with polarization conversion |
| 09/23/2004 | WO2004081005A1 Melanin-concentrating hormone receptor antagonists and compositions and methods related thereto |
| 09/23/2004 | WO2004080990A1 C-glycoside derivatives and salts thereof |
| 09/23/2004 | WO2004080962A1 2,4,6-phenyl substituted cyclic ketoenols |
| 09/23/2004 | WO2004080951A2 Sulfonic acids, their derivatives and pharmaceutical compositions containing them |
| 09/23/2004 | WO2004080947A1 Imino ether derivative compounds and drugs containing the compounds as the active ingredient |
| 09/23/2004 | WO2004080411A2 Melanin-concentrating hormone receptor antagonists and compositions and methods related thereto |
| 09/23/2004 | WO2004080376A2 Hydroxyethylamine compounds having asp2 inhibitory activity for the treatment of alzheimer’s disease |
| 09/23/2004 | WO2004058708B1 Process for producing n-methyl succinimide |
| 09/23/2004 | WO2004050613A3 2-substituted-3-propenamide derivatives and methods of using the same |
| 09/23/2004 | WO2004043884A3 Novel acylating reagents |
| 09/23/2004 | WO2004041217A3 Synthetic lactone formulations and method of use |
| 09/23/2004 | WO2003082268A3 Hemiasterlin derivatives and uses thereof in the treatment of cancer |
| 09/23/2004 | US20040186313 via diethyl-3-methoxyacetoxyglutaric acid as intermediate; deblocking, deprotecting; Friedel-Crafts acylation; hydroxymethylglutaryl coenzyme a reductase inhibitors; anticholesterol agents |
| 09/23/2004 | US20040186287 heterocyclic imines such as 2-(2,6-difluorophenyl)-5-phenyl-3,4-dihydro-2H-pyrrole, formed by cyclocondensation, for use as insecticides or miticides |
| 09/23/2004 | US20040186162 preparation of the amorphous inhibitor and its hydrates of desired particle size which comprises dissolving the inhibitor in a hydroxylic solvent (methanol), then removing the solvent by freeze-drying |
| 09/23/2004 | US20040186154 treating or preventing a hypercholesterolemia-related or an inflammation-related condition ; apical sodium co-dependent bile acid transport inhibitor and an amount of a cyclooxygenase-2 (COX-2) selective inhibitor or its prodrug; kits |
| 09/23/2004 | US20040186146 E.g., R-N-2-[4-(pyrrolidin-1'-yl)methylphenyl]propionyl-methanesulfonamide; inhibition of chemotaxis of neutrophils induced by interleukin-8; antiinflammatory agents; psoriasis, ulcerative cholitis, glomerular nephritis, acute respiratory insufficiency, idiopathic fibrosis, and rheumatoid arthritis |
| 09/23/2004 | US20040186145 Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use and pharmaceutical preparations comprising them |
| 09/23/2004 | US20040186143 Lactams as modulators of chemokine receptor activity |
| 09/23/2004 | US20040186140 Cyclic derivatives as modulators of chemokine receptor activity |
| 09/23/2004 | US20040186099 Novel heterocyclic compounds, their preparation, pharmaceutical compositions containing them and their use in medicine |
| 09/23/2004 | US20040186098 Method for preventing and treating hearing loss using sensorineurotrophic compounds |
| 09/23/2004 | US20040186090 New amidino derivatives and their use as thrombin inhibitors |
| 09/23/2004 | US20040186088 Mercapto-cycloalkyl or heterocyclyl ring-sulfonyl-aryl or heteroaryl derivatives; preventing the cleavage Of tumor necrosis factor- alpha from cell membranes in mammal; treating autoimmune diseases, inflammation, inflammatory bowel disease, Crohn's disease, asthma, sepsis and septic shock |
| 09/23/2004 | US20040185539 Process for the preparation of 2-hydroxymethyl-pyrolidine 3, 4-diols |
| 09/23/2004 | US20040185352 Photothermographic element comprising improved base precursors and methods for their use |
| 09/23/2004 | DE10311300A1 New 2-alkoxy-4-halo-6-alkylphenyl-substituted (hetero)cyclic ketoenols, useful as total or selective herbicides and pesticides, e.g. insecticides, acaricides and nematocides for plant protection |
| 09/23/2004 | CA2518986A1 Imino ether derivative compounds and drugs containing the compounds as the active ingredient |
| 09/23/2004 | CA2514988A1 Sulfonic acids, their derivatives and pharmaceutical compositions containing them |
| 09/22/2004 | EP1460063A1 Metal complexes of heterocyclic aromatic compounds |
| 09/22/2004 | EP1460062A1 Nitrogenous cyclic ketone derivative, process for producing the same, and use |
| 09/22/2004 | EP1460061A1 Process for producing 1-alkoxycarbonyl nitrogenous saturated heterocyclic derivative |
| 09/22/2004 | EP1459763A1 Drug for preventing vascular restenosis and instrument to be embedded in vessel coated with the drug |
| 09/22/2004 | EP1458684A2 Therapeutic heterocycles |
| 09/22/2004 | EP1458680A1 Prodrugs to d-prolines |
| 09/22/2004 | EP1458679A2 Pyrrolidine derivatives as prostaglandin modulators |
| 09/22/2004 | EP1458375A2 Compositions for decreasing activity of hormone-sensitive lipase |
| 09/22/2004 | EP1458374A2 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase |
| 09/22/2004 | EP1124801B1 Piperidine and pyrrolidine derivatives comprising a nitric oxide donor for treating stress |
| 09/22/2004 | EP1100503B1 Non-imidazole alkylamines as histamine h 3?-receptor ligands and their therapeutic applications |
| 09/22/2004 | EP1093454B1 Chiral compounds and their use as doping agents in liquid crystals |
| 09/22/2004 | EP0805148B1 Benzamidoxime derivative, process for production thereof, and agrohorticultural bactericide |
| 09/21/2004 | US6794545 Conformationally restricted polyamine analogs as disease therapies |
| 09/21/2004 | US6794519 Reacting an amino alcohol derivative with a sulfonyl halide in a mixed solvent composed of an aprotic organic solvent and water in the presence of a non- water-prohibiting inorganic base to produce sulfonic acid ester derivative |
| 09/21/2004 | US6794516 Synthesis of clasto-lactacystin β-lactone and analogs thereof |
| 09/21/2004 | US6794511 An enzyme inhibitors of metalloprotease; treating connective tissue degradation caused by inflammation or tumor |
| 09/21/2004 | US6794400 4-substituted-1-(arylmethylidene)thiosemicarbazide, 4-substituted-1-(arylcarbonyl)thiosemicarbazide and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 09/21/2004 | US6794397 Substituted nicotinamides and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 09/21/2004 | US6794392 Cell differentiation inducer |
| 09/21/2004 | US6794365 Inhibitors of the blood clotting enzyme factor xa; treating thromboembolic diseases; trifluoroacetic acid salt of 2-(4-carbamimidoyl-benzyl)-n-((1-carbamoyl-4-guanidino-butylcarbamoyl) -cyclohexyl-methyl)-n',n'-dimethyl-malonamide |
| 09/21/2004 | CA2189297C Process for preparing 1-substituted pyrrole-3-carboxylic acid derivatives |
| 09/16/2004 | WO2004078988A1 Process for production of aromatic diols |
| 09/16/2004 | WO2004078732A1 N-aryl heteroaromatic products, compositions containing same and use thereof |
| 09/16/2004 | WO2004078718A1 Compounds having activity at 5ht2c receptor and uses thereof |
| 09/16/2004 | WO2004078717A1 Acylated piperazine derivatives as melanocortin-4 receptor agonists |
| 09/16/2004 | WO2004078716A1 Acylated piperazine derivatives as melanocortin-4 receptor agonists |
| 09/16/2004 | WO2004078703A1 Acid generators, sulfonic acids, sulfonyl halides, and radiation-sensitive resin compositions |
| 09/16/2004 | WO2004078103A2 G-lactam derivatives as prostaglandin agonists |
| 09/16/2004 | WO2004071445A3 2-(aminomethyl)arylamide analgesics |
| 09/16/2004 | WO2004069782A3 2-aryl-acetic acids, their derivatives and pharmaceutical compositions containing them |
| 09/16/2004 | WO2004064972A9 Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions |
| 09/16/2004 | WO2004050653A3 Oxime ester photoinitiators with heteroaromatic groups |
| 09/16/2004 | WO2004047730A3 Compounds for inhibition of hiv infection by blocking hiv entry |
| 09/16/2004 | WO2004026264A3 Novel aromatic compounds possessing antifungal or antibacterial activity |
| 09/16/2004 | WO2004010943A3 Substituted benzanilides as modulators of the ccr5 receptor |
| 09/16/2004 | WO2003028729A3 Prodrugs of substituted polycyclic compounds useful for selective inhibition of the coagulation cascade |
| 09/16/2004 | US20040181075 Process of making chalcone derivatives |
| 09/16/2004 | US20040181063 such as 1-C-(5-N-benzyloxymethyl-4-methoxy pyrrolo[3,2-d]pyrimidin-7-yl)-1,4-dideoxy-1,4-imino-2,3-O-isopropylidene-D-ribitol; potent inhibitors of purine nucleoside phosphorylase and useful for suppressing T-cell function and/or treating and/or preventing infections caused by protozoan parasites |
| 09/16/2004 | US20040180964 anti-obestic activity; Neuropeptide Y antagonist |
| 09/16/2004 | US20040180927 Inhibitors of cysteine protease |
| 09/16/2004 | US20040180925 such as (S)-1-[2-(2-Pyrazinylamino)ethylamino]acetyl-2-pyrrolidinecarbonitrile dimethanesulfonate |
| 09/16/2004 | US20040180892 control of cardiovascular homeostasis is achieved through a combination of both direct neuronal control and systemic neurohormonal activation |
| 09/16/2004 | US20040180889 Cancer treatment; such as [4-(2,5-dimethyl-pyrrol-1-yl)-3-methyl-phenoxy]-acetic acid |
| 09/16/2004 | US20040180880 Piperazine and piperidine derivatives |
| 09/16/2004 | CA2513652A1 G-lactam derivatives as prostaglandin agonists |
| 09/16/2004 | CA2512243A1 N-aryl heteroaromatic products, compositions containing same and use thereof |
| 09/15/2004 | EP1457490A1 5-membered N-heterocyclic compounds with hypoglycemic and hypolipidemic activity |
| 09/15/2004 | EP1457485A1 Sulfonic acids, their derivatives and pharmaceutical compositions containing them |